Cover Image

A case of sustained tumor regression with MP0274, a novel DARPin therapeutic targeting human epidermal growth factor receptor 2 signaling, in metastatic human epidermal growth factor receptor 2-positive breast cancer after prior Trastuzumab and Pertuzumab

Saved in:
Bibliographic Details
Main Authors: Fischer, Stefanie (Author) , Götze, Thorsten O. (Author) , Omlin, Aurelius (Author) , Baird, Richard D. (Author) , Dawson, Keith M. (Author) , Zitt, Christof (Author) , Arany, Zita (Author) , Tresch, Gaby (Author) , Fiedler, Ulrike (Author) , Jeger, Simone (Author) , Fung, Samson (Author) , Legenne, Philippe (Author) , Leupin, Nicolas (Author) , Schneeweiss, Andreas (Author) , Fremd, Carlo (Author)
Format: Article (Journal)
Language:English
Published: November 3, 2022
In: JCO precision oncology
Year: 2022, Volume: 6, Pages: 1-8
ISSN:2473-4284
DOI:10.1200/PO.22.00006
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/PO.22.00006
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/PO.22.00006
Get full text
Author Notes:Stefanie Fischer, Thorsten O. Götze, Aurelius Omlin, Richard D. Baird, Keith M. Dawson, Christof Zitt, Zita Arany, Gaby Tresch, Ulrike Fiedler, Simone Jeger, Samson Fung, Philippe Legenne, Nicolas Leupin, Andreas Schneeweiss, and Carlo Fremd
Description
Item Description:Gesehen am 23.06.2023
Physical Description:Online Resource
ISSN:2473-4284
DOI:10.1200/PO.22.00006

Similar Items